logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11136317 B1

PDFFull Text
Expired
Date of Patent:
Oct. 05, 2021

Filed:

Jan. 30, 2020

Nadph oxidase 4 inhibitors

Applicant:

Actelion Pharmaceuticals Ltd, Allschwil, CH;

Inventors:

Hamed Aissaoui, Allschwil, CH;

Martin Bolli, Allschwil, CH;

Christoph Boss, Allschwil, CH;

Sylvia Richard-Bildstein, Allschwil, CH;

Patrick Sieber, Allschwil, CH;

Assignee:

Actelion Pharmaceuticals LTD, Allschwil, CH;

Attorney:

Hoxie & Associates LLC

Primary Examiner:

Susanna Moore

Int. Cl.
CPC ...
C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/12 (2006.01); C07D 263/54 (2006.01); C07D 263/58 (2006.01); C07D 277/62 (2006.01); C07D 417/14 (2006.01); C07D 471/10 (2006.01); C07D 491/107 (2006.01); A61P 11/00 (2006.01); A61P 35/04 (2006.01);
U.S. Cl.
CPC ...
C07D 413/12 (2013.01); A61P 11/00 (2018.01); A61P 35/04 (2018.01); C07D 263/54 (2013.01); C07D 263/58 (2013.01); C07D 277/62 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/10 (2013.01); C07D 491/107 (2013.01);
Abstract

The invention relates to 2,5-disubstituted benzoxazole and benzothiazole derivatives of Formula (I) wherein L, X, Y, and ring (A) are as described in the description, their preparation and their use as pharmaceutically active compounds. Said compounds may be useful for the prevention or treatment of diseases or disorders associated with impaired reactive oxygen species (ROS) production, and/or for the prevention or treatment of various fibrotic diseases.

Find Patent Forward Citations

Aissaoui, Hamed. (2021). Nadph oxidase 4 inhibitors (U.S. Patent No. 11136317). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11136317

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…